Culturing CLL cells in media lacking Wnt5a resulted in rapid reduction in the levels of phosphorylated cortactin, which could be restored by treatment of CLL cells with exogenous Wnt5a. Here, CTTN is linked to B-cell chronic lymphocytic leukemia.